Forward Industries Submits $4 Billion Shelf Registration to Support Solana Treasury Investment
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 17 2025
0mins
Source: Benzinga
Forward Industries' Registration: Forward Industries Inc. filed an automatic shelf registration with the SEC for an at-the-market equity program worth up to $4 billion, aimed at raising funds for working capital, asset purchases, and expanding its Solana token strategy.
Investment in Solana: The company has invested $1.58 billion in Solana tokens, reflecting a trend among firms adopting crypto treasury management strategies, with other companies like Helius Medical Technologies and Upexi also building significant Solana reserves.
Analyst Views on UPXI
Wall Street analysts forecast UPXI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UPXI is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.100
Low
6.00
Averages
6.00
High
6.00
Current: 2.100
Low
6.00
Averages
6.00
High
6.00
About UPXI
Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
